IDiyas

For the Inventor, By the Inventor

Kyungki-do, South Korea

Ho-Seok Kwon

USPTO Granted Patents = 10


Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Suweon, KR (1998 - 1999)
  • Kyounggi-do, KR (2000)
  • Kyungki-do, KR (2000 - 2007)
  • Suwon-si, KR (2010)

Company Filing History:

goldMedal8 out of 13 
 
Samjin Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 1 
 
Samjin Pharmaceuticazl Co., Ltd.
 patent
bronzeMedal1 out of 1 
 
Korea Research Inst. of Chem. Tech.
 patent
4. 1 out of 2 
 
Samjin Pharm. Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1998-2010

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 7851479 - Use of pyrimidinedione derivative for preventing or treating hepatitis C (2010-12-14),
2. 7230105 - 9-aminoacridine derivatives and process for the preparation thereof (2007-06-12),
3. 6987114 - Antiviral pyrimidinedione derivatives and process for the preparation thereof (2006-01-17),
4. 6683184 - Piperazine derivatives and process for the preparation thereof (2004-01-27),
5. 6620936 - 9-aminoacridine derivatives and process for the preparation thereof (2003-09-16),
6. 6274732 - Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione (2001-08-14),
7. 6136815 - Antiviral 2,4-pyrimidinedione derivatives and process for the (2000-10-24),
8. 6028195 - Piperazine derivatives and process for the preparation thereof (2000-02-22),
9. 5922727 - Antiviral substituted pyrimidinedione homocarbocyclic nucleoside (1999-07-13),
10. 5780472 - Piperazine derivatives and methods for the preparation thereof and (1998-07-14),

Title: Innovator Spotlight: Ho-Seok Kwon

Introduction: Ho-Seok Kwon, hailing from Kyungki-do, South Korea, is a notable inventor with a remarkable portfolio that includes 10 patents. His contributions primarily focus on pharmacological innovations, which have the potential to affect treatment protocols in significant ways.

Latest Patents: Among his recent inventions, Kwon has developed the "Use of pyrimidinedione derivative for preventing or treating hepatitis C." This invention highlights a pyrimidinedione derivative that exhibits excellent inhibitory activity against the hepatitis C virus, providing a promising avenue for therapeutic intervention. Additionally, his patent on "9-aminoacridine derivatives and process for the preparation thereof" introduces a new 9-aminoacridine derivative that demonstrates significant antitumor activity while maintaining low toxicity, showcasing his commitment to advancing medical research.

Career Highlights: Ho-Seok Kwon has made significant strides during his career, contributing to pharmaceutical advancements. He has been associated with reputable companies such as Samjin Pharmaceutical Co., Ltd. and Samjin Pharmaceutical Co., Ltd., where his research and development efforts have laid the groundwork for innovative therapeutic solutions.

Collaborations: Throughout his career, Kwon has collaborated with notable individuals in the field, including colleagues Eui-Hwan Cho and Sun-Gan Chung. These partnerships have enhanced his research impact and fostered an environment conducive to innovation.

Conclusion: Ho-Seok Kwon stands out as a significant figure in the realm of pharmaceutical innovations. With a series of impactful patents, he is poised to make lasting contributions to the medical field. His dedication to research continues to inspire fellow inventors and highlight the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…